Last week during the American College of Rheumatology Conference in Philadelphia, the SRF hosted two meetings to convene Principal Investigators and Research Coordinators from all 17 institutions participating in the…
New research: a study based on data from the SRF-launched CONQUER Registry finds that gastrointestinal (GI) symptoms in those with systemic scleroderma are unrelated to scleroderma-specific medications. This study, led…
Double your impact with a gift to our 2022 Research Challenge! We’re excited to share that SRF Board Chair, Luke Evnin, PhD, and Research Committee Chair, Deann Wright, have once again committed…